Suchergebnisse - (Subject:"*Disease Progression")

PubPharm (6.540)

41

Monitoring of Early Disease Progression in Hereditary Transthyretin Amyloidosis : Monitoring of Early Disease Progression in Hereditary Transthyretin Amyloidosis

enthalten in: ClinicalTrials.gov | 2024

42

Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer Progression : Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer Progression: A Double-Blind Randomized Controlled Trial

enthalten in: ClinicalTrials.gov | 2024

43

Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study : Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study

enthalten in: ClinicalTrials.gov | 2024

44

A national registry-based study of ethnic differences in people with multiple sclerosis in Iran

enthalten in: Clinical neurology and neurosurgery | 2024

von Ashtari, F. | Kavosh, A. | Baghbanian, S. | +9

45

Study of Denosumab for Prevention of Skeletal Disease Progression in Children With Fibrous Dysplasia : A Phase 2 Study of Denosumab for Prevention of Skeletal Disease Progression in Children With Fibrous Dysplasia

enthalten in: ClinicalTrials.gov | 2024

46

Pembrolizumab/Vibostolimab Coformulation (MK-7684A) or Pembrolizumab/Vibostolimab Coformulation Plus Docetaxel Versus Docetaxel for Metastatic Non Small Cell Lung Cancer (NSCLC) With Progressive Disease After Platinum Doublet Chemotherapy and Immunotherapy (MK-7684A-002, KEYVIBE-002) : A Phase 2, Multicenter, Randomized Study to Compare the Efficacy and Safety of MK-7684A or MK-7684A Plus Docetaxel Versus Docetaxel Monotherapy in the Treatment of Participants With Metastatic Non-small Cell Lung Cancer With Progressive Disease After Treatment With a Platinum Doublet Chemotherapy and Immunotherapy

enthalten in: ClinicalTrials.gov | 2024

47

Pembrolizumab/Vibostolimab Coformulation (MK-7684A) or Pembrolizumab/Vibostolimab Coformulation Plus Docetaxel Versus Docetaxel for Metastatic Non Small Cell Lung Cancer (NSCLC) With Progressive Disease After Platinum Doublet Chemotherapy and Immunotherapy (MK-7684A-002, KEYVIBE-002) : A Phase 2, Multicenter, Randomized Study to Compare the Efficacy and Safety of MK-7684A or MK-7684A Plus Docetaxel Versus Docetaxel Monotherapy in the Treatment of Participants With Metastatic Non-small Cell Lung Cancer With Progressive Disease After Treatment With a Platinum Doublet Chemotherapy and Immunotherapy

enthalten in: ClinicalTrials.gov | 2024

48

Study of Denosumab for Prevention of Skeletal Disease Progression in Children With Fibrous Dysplasia : A Phase 2 Study of Denosumab for Prevention of Skeletal Disease Progression in Children With Fibrous Dysplasia

enthalten in: ClinicalTrials.gov | 2024

49

Improving our understanding of the paradoxical protective effect of obesity on radiographic damage : a large magnetic resonance imaging-study in early arthritis

enthalten in: Rheumatology (Oxford, England) | 2024

von den Hollander, N. | van der Helm-van Mil, A. | van Steenbergen, H.

50

Machine learning models with time-series clinical features to predict radiographic progression in patients with ankylosing spondylitis

enthalten in: Journal of rheumatic diseases | 2024

von Koo, B. | Jang, M. | Oh, J. | +5